SURFACE MODIFICATION OF NANOPARTICLES TO OPPOSE UPTAKE BY THE MONONUCLEAR PHAGOCYTE SYSTEM

被引:711
作者
STORM, G
BELLIOT, SO
DAEMEN, T
LASIC, DD
机构
[1] UNIV GRONINGEN,INST DRUG EXPLORAT,INST DRUG STUDIES,DEPT PHYSIOL CHEM,GRONINGEN,NETHERLANDS
[2] MEGA BIOS CORP,SAN CARLOS,CA
关键词
NANOPARTICLE; COLLOIDAL CARRIER; SURFACE MODIFICATION; STERIC STABILIZATION; PHARMACOKINETICS; BIODISTRIBUTION; HYDROPHILIC COATING; POLYMERIC SURFACTANT; POLOXAMER; POLOXAMINE; POLYETHYLENE GLYCOL; OPSONIZATION; MONONUCLEAR PHAGOCYTE SYSTEM;
D O I
10.1016/0169-409X(95)00039-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An overview of recent advances in the surface modification of colloidal particles to oppose uptake by the mononuclear phagocyte system (MPS) is presented. First, we describe the colloidal particles and hydrophilic coating materials investigated, with particular focus on the literature concerning particles other than liposomes. Then the pharmacokinetics and biodistribution of these MPS-opposing systems are summarized. Finally, the mechanism behind the MPS-avoidance phenomenon is discussed in the light of the concept of steric stabilization, We conclude that the literature reviewed provides enough promise for anticipating therapeutic and diagnostic applications of surface-modified nanoparticles.
引用
收藏
页码:31 / 48
页数:18
相关论文
共 109 条
[1]  
ABRA RM, 1980, RES COMMUN CHEM PATH, V29, P349
[2]  
ADLERSBERG L, 1969, J RETICULOENDOTH SOC, V6, P536
[3]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[4]   LONG-CIRCULATING (STERICALLY STABILIZED) LIPOSOMES FOR TARGETED DRUG-DELIVERY [J].
ALLEN, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :215-220
[5]  
ALLEN TM, 1994, ADV DRUG DELIV REV, V13, P185
[6]  
ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
[7]  
BAKKERWOUDENBER.IA, 1993, J INFECT DIS, V168, P164
[8]  
BAKKERWOUDENBER.IA, 1992, BIOCHIM BIOPHYS ACTA, V1138, P318
[9]  
BAKKERWOUDENBER.IA, 1994, J DRUG TARGET, V2, P363
[10]  
Bayer E., 1992, POLYETHYLENE GLYCOL, P325